Fintel reports that on December 12, 2025, Wells Fargo upgraded their outlook for Relay Therapeutics (NasdaqGM:RLAY) from Equal-Weight to Overweight.
Analyst Price Forecast Suggests 77.23% Upside
As of December 6, 2025, the average one-year price target for Relay Therapeutics is $14.18/share. The forecasts range from a low of $6.06 to a high of $19.95. The average price target represents an increase of 77.23% from its latest reported closing price of $8.00 / share.
https://www.nasdaq.com/articles/wells-fargo-upgrades-relay-therapeutics-rlay
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.